Skip to main content
. 2014 Dec 7;20(45):17141–17147. doi: 10.3748/wjg.v20.i45.17141

Table 2.

Mean survival periods and survival rates of different groups

Groups Mean survival periods (mo) 1 yr survival rate 2 yr survival rate 3 yr survival rate
Conservative treatment 3.8 0% 0% 0%
TACE 7.0 17.5% 0% 0%
Hepatic resection 8.2 28% 20% 15%
Hepatic resection with TACE 15.1 49% 37% 19%

TACE: Transarterial chemoembolization.